Structure of central airways in current smokers and ex-smokers with and without mucus hypersecretion: relationship to lung function
- PMID: 3424265
- PMCID: PMC461007
- DOI: 10.1136/thx.42.11.843
Structure of central airways in current smokers and ex-smokers with and without mucus hypersecretion: relationship to lung function
Abstract
Forty-five patients who underwent thoracotomy and lung resection for tumour were studied to compare the structure of the central airways in current smokers and ex-smokers. The patients were divided into four groups: current smokers with mucus hypersecretion (n = 15), current smokers without mucus hypersecretion (n = 14), ex-smokers with mucus hypersecretion (n = 5), and ex-smokers without mucus hypersecretion (n = 11). Quantitative histological studies of the airway wall showed no difference in gland size, smooth muscle, connective tissue, or Reid index between the groups. The central airways of patients with mucus hypersecretion showed increased mucosal inflammation. The five ex-smokers in whom mucus hypersecretion persisted after they had stopped smoking had both central and peripheral airways affected by the inflammatory response, and these patients also had an abnormal result in the nitrogen washout test.
Similar articles
-
Morphology of peripheral airways in current smokers and ex-smokers.Am Rev Respir Dis. 1983 Apr;127(4):474-7. doi: 10.1164/arrd.1983.127.4.474. Am Rev Respir Dis. 1983. PMID: 6838053
-
Remodeling in response to infection and injury. Airway inflammation and hypersecretion of mucus in smoking subjects with chronic obstructive pulmonary disease.Am J Respir Crit Care Med. 2001 Nov 15;164(10 Pt 2):S76-80. doi: 10.1164/ajrccm.164.supplement_2.2106067. Am J Respir Crit Care Med. 2001. PMID: 11734472 Review.
-
Structure and function of small airways in smokers: relationship between air trapping at CT and airway inflammation.Radiology. 2003 Jul;228(1):85-94. doi: 10.1148/radiol.2281020187. Epub 2003 May 15. Radiology. 2003. PMID: 12750458
-
Relevance of airflow obstruction and mucus hypersecretion to mortality.Respir Med. 1991 Jan;85(1):27-35. doi: 10.1016/s0954-6111(06)80207-6. Respir Med. 1991. PMID: 2014356
-
New pharmacotherapy for airway mucus hypersecretion in asthma and COPD: targeting intracellular signaling pathways.J Aerosol Med Pulm Drug Deliv. 2010 Aug;23(4):219-31. doi: 10.1089/jamp.2009.0802. J Aerosol Med Pulm Drug Deliv. 2010. PMID: 20695774 Review.
Cited by
-
Otorhinolaryngological symptoms among smokeless tobacco (Maras powder) users.North Clin Istanb. 2018 Aug 8;6(3):284-292. doi: 10.14744/nci.2018.50024. eCollection 2019. North Clin Istanb. 2018. PMID: 31650117 Free PMC article.
-
Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease.Am J Respir Crit Care Med. 2006 May 1;173(9):991-8. doi: 10.1164/rccm.200509-1525OC. Epub 2006 Feb 10. Am J Respir Crit Care Med. 2006. PMID: 16474030 Free PMC article.
-
Smoking cessation and bronchial epithelial remodelling in COPD: a cross-sectional study.Respir Res. 2007 Nov 26;8(1):85. doi: 10.1186/1465-9921-8-85. Respir Res. 2007. PMID: 18039368 Free PMC article.
-
Relation between duration of smoking cessation and bronchial inflammation in COPD.Thorax. 2006 Feb;61(2):115-21. doi: 10.1136/thx.2005.040519. Epub 2005 Jul 29. Thorax. 2006. PMID: 16055612 Free PMC article.
-
Effects of cigarette smoke exposure on pulmonary physiology, muscle strength and exercise capacity in a retrospective cohort with 30,000 subjects.PLoS One. 2021 Jun 24;16(6):e0250957. doi: 10.1371/journal.pone.0250957. eCollection 2021. PLoS One. 2021. PMID: 34166381 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources